CPL Market Remained Largely Stable This Week (Nov 17-23, 2017)
Market Review: The Chinese phenol market continued the uptrend this week. Negotiation prices moved up. Up to December 7, the reference negotiation prices for phenol in East China were in the range of RMB 10,200-10,400/mt, up RMB 750/mt week on week. The average price was RMB 10,000/mt, up 6.72% week on week. The benzene prices fluctuated at high levels, but phenol market saw no pressure. Supply and demand were the major influencing factors. The supply was tight in the market, and holders controlled the sales. Phenol producers raised prices again to RMB 10,000/mt. The BPA market followed the uptrend. The profits were fine. Players were cautious and optimistic.
Forecast: The tight supply is the major reason for the firm phenol market. Some imported goods will arrive. But some phenolic ketone units in China will undergo maintenance in the future. Producers will see no sales pressure. It is predicted that the Chinese phenol market will inch up next week.
Looking for chemical products? Let suppliers reach out to you!
2026-06-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Recommend Reading
-
August Epichlorohydrin Market Shows a "V" Shaped Trend in China
-
Demand Fluctuations Drive Butadiene Market to Soar in August
-
Phosphate Market in August Stabilizes After Narrow Fluctuations in China
-
Supply and Demand Weakness, Flexible Fluctuations in the Melamine Market
-
Change Rate Remains Positive, This Round of Refined Oil Retail Prices in China Is About to Increase
-
Syndax Q2 Net Loss Widens to $71.8 Million Despite 43 Percent Revenue Surge and New Drug Momentum
-
Vertex Shares Plunge 14.4 Percent After Pain Drug Trial Misses Key Target and Study Halt
-
Pfizer Lifts 2025 Profit Forecast After Q2 Earnings Beat Sales Hit $14.65 Billion Shares Jump 2.8 Percent
-
L Catterton to Acquire Minority Stake in Perfume Company EX NIHILO
-
Sandoz Set to Slash Canadian Weight-loss Drug Prices by Up to 70 Percent Generics Could Expand Patient Access